Brentuximab vedotin

Adcetris 50 mg, poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 25 Oct 2012

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AdcetrisEuropean UnionAuthorised

AdcetrisBrazil · Takeda Farmaceutica Brasil LtdaSame brand
AdcetrisBrazil · Takeda Pharma Ltda.Same brand
AdcetrisCanada · 50 MG / VIAL · Powder For Solution · Pfizer Canada UlcSame brand
Adcetris 50 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 50 mg · polvo para concentrado para solución para perfusión · Takeda Pharma A/SSame brand
ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 50 mg · polvo para concentrado para solución para perfusión · Takeda Pharma A/SSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Brentuximab vedotin

Adcetris 50 mg, poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 25 Oct 2012

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AdcetrisEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AdcetrisEuropean Union · Takeda Pharma A/S

AdcetrisCroatia

AdcetrisItaly · Concentrato per soluzione per infusione · Takeda Pharma A/S

AdcetrisNew Zealand · Inj 50 mg vial

ADCETRIS 50 mgRomania · 50 mg · pulb. pt. conc. pt. sol. perf. · Takeda Pharma A/S

Adcetris®Serbia · 50mg · prašak za koncentrat za rastvor za infuziju · Takeda DOO

ADCETRIS 50 mg powder for concentrate for solution for infusionSaudi Arabia · BSP PHARMACEUTICALS S.r.l.

Adcetris® Powder for Concentrate for Solution for Infusion 50MG/VialSingapore · 50mg/vial · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.

AdcetrisUnited States · 50MG/VIAL · injectable · Seattle Genetics

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Brentuximab vedotin
Dosage form: Poeder voor concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 25 Oct 2012
Registration: EU/1/12/794
Marketing authorisation holder: Takeda Pharma A/S
ATC code: L01FX05
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/002455
EU number: EU/1/12/794